Brief: Intra-Cellular Therapies Posts Q4 Revenue USD 87.869 Million
01/03/2023 12:41
Mar 1 (Reuters) - Intra-Cellular Therapies * Q4 revenue USD 87.869 million. * Q4 net income USD -44 million
Recent news on Intra-Cellular Therapies
See all newsBrief: Intra-Cellular Therapies stockholder filed lawsuit against co, board in NY Supreme Court
Intra-Cellular Therapies Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Apple, Caterpillar, Visa
Street View: New drug launches, ITCI deal to boost J&J's growth
J&J beats quarterly sales and profit estimates on cancer drug sales (updated)